This report was recently updated on December 14 2024 with the latest and most recent
market numbers
Global Cell & Gene Therapy Manufacturing Market Size, Trends & Analysis - Forecasts to 2028 By Type Scope (Cell Therapy- (Allogeneic, Autologous), Gene Therapy – (Viral Vectors, Non-Viral Vectors)), By Scale (R&D Scale Manufacturing, Commercial-Scale Manufacturing), By Workflow (Cell Processing & Banking, Process Development, Fill & Finish Operations, Analytical & Quality Testing, Vector Production, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), Company Market Share Analysis, and Competitor Analysis
The global cell & gene therapy manufacturing market is valued at USD 15.1 billion in 2022 and is projected to grow at a CAGR of 19.6% from 2023 to 2028.
The tremendous potential of cellular therapies in the treatment of rare and chronic ailments, as shown by several developmental advances and research findings, has attracted the attention of stakeholders in the healthcare business in recent years. This is evident by the constant increase in the number of clinical trials carried out for the manufacturing of cell therapies, thereby driving the growth of the cell & gene therapy manufacturing market.
Scientific innovations and well-established manufacturing plants are helping the global cell & gene manufacturing market to grow substantially. For example, in March 2021, Tevogen Bio announced a collaboration with BioCentriq, a New Jersey-based cell and gene therapy development and manufacturing facility, to assist in the clinical manufacturing of Tevogen's experimental COVID-19 therapy. Such initiatives by companies are expected to drive the growth of both companies in this space.
Furthermore, due to the increasing pressure of meeting consumer demands within the pharmaceutical sector coupled with increased government funding to support research and development initiatives for CAR-T therapies, the global cell & gene therapy market is estimated to grow rapidly during the forecast period. Also, stem cell treatments exhibit wide application in clinical research as well as in treating diseases. These factors are anticipated to drive the global cell & gene therapy manufacturing market during the forecast period.
Being a key step in cell and gene therapy development, the process development segment is expected to witness the major share in the market during the forecast period of 2023-2028. Technological advancements is one of the key factors that are contributing to the growth of this segment. Introduction of continuous manufacturing along with increasing popularity of single-use bioprocessing solutions is supportive to the dominance of this segment in 2022.
On the other hand, the vectors production segment is expected to grow the fastest during 2023-2028. This is due increasing number of contract service providers that offering platform to provide viral as well as non-viral vectors to support therapy development. Furthermore, large-scale manufacture of gene therapy vectors has been made possible by the success of clinical studies including gene therapy treatments for prevalent conditions like Parkinson's disease, Alzheimer's disease, and rheumatoid arthritis.
The cell therapy segment is estimated to account for the largest share of the 2022 market during the forecast period. Stem cell therapy has become a very promising and advanced scientific study area in recent years. The advancement of medical procedures has sparked high hopes. This cutting-edge therapy marks a turning point in contemporary medicine, bringing hope for diseases that are currently incurable.
The gene therapy segment is expected to grow the fastest during 2023-2028. The steep rise in market capitalization of prominent CAR-T biotech companies like Juno, Kite, and Collects in recent years demonstrates increased market investment in this field. Collaborations between giant pharma companies like Bluebird and biotech businesses like Celgene are one of the most effective ways for companies to increase their market share. The gene therapies have been identified as possible game-changers by biopharma investors, both return-oriented and strategic.
The R&D scale manufacturing segment is expected to witness the largest share in the global market during the forecast period of 2023-2028. R&D for cell and gene therapy includes the identification, production, and processing of cells for clinical applications. It helps in providing high-quality and nurtured cells. Increased funding for manufacturing companies, advanced technologies, and demand in the market drive the R&D scale manufacturing segment substantially.
The commercial-scale manufacturing diseases segment is expected to grow the fastest during 2023-2028. Commercial-scale helps in pre-clinical trials and the results have the potential to treat chronic diseases under various verticals. CAR t-cell trials help in resisting or non-relapse of cancer and this drives the market during the forecast period.
North America dominated the 2022 market and is expected to maintain this trend during the forecast period of 2023-2028. This can be attributed to the presence of a substantial number of biopharmaceutical contract manufacturers in the U.S. coupled with the increase in biomedical R&D programs. With well-established healthcare and regulatory infrastructure, the U.S. is a hub for complex medical treatments for many people around the world. This has positively influenced the cell & gene therapy manufacturing industry in the United States.
Asia-Pacific is expected to grow the fastest during 2023-2028. The demand for cell and gene therapies is anticipated to increase in the region over the projected period due to growing research and the availability of innovative immunotherapies on a worldwide scale with markets like Southeast Asia, Korea, and India at the forefront.
With the most clinical studies for CAR-T therapies filed and registered in China, this country has recently become a prospective market for these treatments. Focused efforts on government spending and reforms in the nation have produced tremendous growth, demonstrating the fastest CAGR in the area as a result. Furthermore, due to collaborative research projects, renowned companies like the Thermo Fischer Scientific and Catalent Inc. are expanding their business in Europe for cell therapy as well as treatments for pre-cancer indications.
Thermo Fisher Scientific, Lonza, Merck KGaA, Catalent Inc., Takara, Samsung Biologics, Novartis AG, Apceth Biopharm, and Charles River among others are some key players in the cell & gene therapy manufacturing market.
Please note: This is not an exhaustive list of companies profiled in the report.
These market players are engaged in undertaking multiple strategic measures such as strategic alliances between companies, facility expansion, and mergers of small and emerging companies; to expand their business presence in cell & gene therapy manufacturing and commercialization space.
For instance, in April 2022, Novartis announced commercial licensure approval from the U.S. FDA for its Durham, North Carolina-based multi-product gene therapy manufacturing facility. Such initiatives are anticipated to intensify the market competition and impact the market growth positively.
Chapter 1 Research Methodology
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GME’s Internal Database
1.3.3 Primary Research
1.3.4 Secondary Sources & Third-Party Perspectives
1.3.4.1 Company Information Sources
1.3.4.2 Secondary Data Sources
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Top-Down Approach
1.7.1.2 Bottom-Up Approach
1.8 Market Segmentation & Scope
1.9 Market Definition
Chapter 2 Executive Summary
2.1 Global Market Outlook
2.2 By Type Scope Outlook
2.3 By Scale Outlook
2.4 By Workflow Outlook
2.5 Regional Outlook
Chapter 3 Global Cell & Gene Therapy Manufacturing Market Trend Analysis
3.1. Market Introduction
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on the Cell & Gene Therapy Manufacturing Market
3.4 Metric Data based on the industry
3.5 Market Dynamic Analysis
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.5.4 Industry Opportunities
3.6 Porter’s Five Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Substitution Threat
3.6.4 Threat from New Entrant
3.7 Market Entry Strategies
Chapter 4 Cell & Gene Therapy Manufacturing Market: By Type Scope Trend Analysis
4.1 By Type Scope: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
4.2 Cell Therapy
4.2.1 Market Estimates & Forecast Analysis of Cell Therapy Segment, By Region, 2020-2028 (USD Million)
4.2.1.1 Market Estimates & Forecast Analysis of Allogeneic Cell Therapy Segment, By Region, 2020-2028 (USD Million)
4.2.1.2 Market Estimates & Forecast Analysis of Autologous Cell Therapy Segment, By Region, 2020-2028 (USD Million)
4.3 Gene Therapy
4.3.1 Market Estimates & Forecast Analysis of Gene Therapy Segment, By Region, 2020-2028 (USD Million)
4.3.1.1 Market Estimates & Forecast Analysis of Viral Vectors Gene Therapy Segment, By Region, 2020-2028 (USD Million)
4.3.1.2 Market Estimates & Forecast Analysis of Non-Viral Vectors Gene Therapy Segment, By Region, 2020-2028 (USD Million)
Chapter 5 Cell & Gene Therapy Manufacturing Market: By Workflow Trend Analysis
5.1 By Workflow: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
5.2 Cell Processing & Banking
5.2.1 Market Estimates & Forecast Analysis of Cell Processing & Banking, By Region, 2020-2028 (USD Million)
5.3 Process Development
5.3.1 Market Estimates & Forecast Analysis of Process Development Market Segment, By Region, 2020-2028 (USD Million)
5.4 Fill & Finish Operations
5.4.1 Market Estimates & Forecast Analysis of Fill & Finish Operations Segment, By Region, 2020-2028 (USD Million)
5.4 Analytical & Quality Testing
5.4.1 Market Estimates & Forecast Analysis of Analytical & Quality Testing Segment, By Region, 2020-2028 (USD Million)
5.4 Vector Production
5.4.1 Market Estimates & Forecast Analysis of Vector Production Segment, By Region, 2020-2028 (USD Million)
5.4 Others
5.4.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2020-2028 (USD Million)
Chapter 6 Cell & Gene Therapy Manufacturing Market: By Scale Trend Analysis
6.1 By Scale: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
6.2 R&D Scale Manufacturing
6.2.1 Market Estimates & Forecast Analysis of R&D Scale Manufacturing Segment, By Region, 2020-2028 (USD Million)
6.3 Commercial-Scale Manufacturing
6.3.1 Market Estimates & Forecast Analysis of Commercial-Scale Manufacturing Segment, By Region, 2020-2028 (USD Million)
Chapter 7 Cell & Gene Therapy Manufacturing Market, By Region
7.1 Regional Outlook
7.2 North America
7.2.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Million)
7.2.2 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.2.3 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.2.4 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.2.5 U.S.
7.2.5.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.2.5.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.2.5.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.2.6 Canada
7.2.6.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.2.6.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.2.6.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.7 Mexico
7.5.5.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.5.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.5.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3 Europe
7.3.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Million)
7.3.2 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.3 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.4 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.5.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.5.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.6 UK
7.3.6.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.6.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.6.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.7 France
7.3.7.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.7.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.7.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.8 Netherlands
7.3.8.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.8.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.8.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.9 Italy
7.3.9.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.9.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.9.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.10 Spain
7.3.10.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.10.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.10.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.11 Rest of Europe
7.3.11.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.11.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.11.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Million)
7.4.2 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.4.3 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.4.4 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.4.5 China
7.4.5.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.4.5.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.4.5.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.4.6 India
7.4.6.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.4.6.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.4.6.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.4.7 Japan
7.4.7.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.4.7.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.4.7.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.4.8 South Korea
7.4.8.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.4.8.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.4.8.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.4.9 Thailand
7.4.9.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.4.9.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.4.9.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.10 Indonesia
7.3.10.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.10.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.10.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.11 Malaysia
7.3.11.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.11.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.11.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.12 Singapore
7.3.12.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.12.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.12.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.13 Vietnam
7.3.13.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.13.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.13.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.3.14 Rest of APAC
7.3.14.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.3.14.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.3.14.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5 Central & South America
7.5.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Million)
7.5.2 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.3 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.4 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.5.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.5.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.6 Argentina
7.5.6.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.6.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.6.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.7 Chile
7.5.7.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.7.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.7.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.8 Rest of Central & South America
7.5.8.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.8.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.8.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.6 Middle East & Africa
7.6.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Million)
7.6.2 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.6.3 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.6.4 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.6.5 Saudi Arabia
7.6.5.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.6.5.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.6.5.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.6.6 United Arab Emirates
7.6.6.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.6.6.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.6.6.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.6.7 South Africa
7.6.7.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.6.7.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.6.7.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.8 Israel
7.5.8.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2028 (USD Million)
7.5.8.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2028 (USD Million)
7.5.8.3 Market Estimates & Forecast Analysis, By Scale, 2020-2028 (USD Million)
7.5.9 Rest of Middle East & Africa
7.5.9.1 Market Estimates & Forecast Analysis, By Type Scope, 2020-2029 (USD Million)
7.5.9.2 Market Estimates & Forecast Analysis, By Workflow, 2020-2029 (USD Million)
7.5.9.3 Market Estimates & Forecast Analysis, By Scale, 2020-2029 (USD Million)
Chapter 8 Competitive Analysis
8.1 Key Global Players, Recent Developments & their Impact on the Industry
8.2 Four Quadrant Competitor Positioning Matrix
8.2.1 Key Innovators
8.2.2 Market Leaders
8.2.3 Emerging Players
8.2.4 Market Challengers
8.3 Vendor Landscape Analysis
8.4 End-User Landscape Analysis
8.5 Company Market Share Analysis, 2022
Chapter 9 Company Profile Analysis
9.1 Thermo Fischer Scientific
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Strategic Initiatives
9.1.4 Product Benchmarking
9.2 Lonza
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Strategic Initiatives
9.2.4 Product Benchmarking
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Strategic Initiatives
9.3.4 Product Benchmarking
9.4 Catalent Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Strategic Initiatives
9.4.4 Product Benchmarking
9.5 Takara
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Strategic Initiatives
9.5.4 Product Benchmarking
9.6 Samsung Biologics
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Strategic Initiatives
9.6.4 Product Benchmarking
9.7 Novartis AG
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Strategic Initiatives
9.7.4 Product Benchmarking
9.8 Apceth Biopharm
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Strategic Initiatives
9.8.4 Product Benchmarking
9.9 Charles River
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Strategic Initiatives
9.9.4 Product Benchmarking
9.10 Other Companies
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Strategic Initiatives
9.10.4 Product Benchmarking
List of Tables
1 Technological Advancements in Cell & Gene Therapy Manufacturing Market
2 Global Cell & Gene Therapy Manufacturing Market: Key Market Drivers
3 Global Cell & Gene Therapy Manufacturing Market: Key Market Challenges
4 Global Cell & Gene Therapy Manufacturing Market: Key Market Opportunities
5 Global Cell & Gene Therapy Manufacturing Market: Key Market Restraints
6 Global Cell & Gene Therapy Manufacturing Market Estimates & Forecast Analysis, 2020-2028 (USD Million)
7 Global Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
8 Cell Therapy: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
9 Gene Therapy: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
10 Global Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
11 Cell Processing & Banking: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
12 Fill & Finish Operations: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
13 Process Development: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
14 Analytical & Quality Testing: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
15 Vector Production: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
16 Others: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
17 Global Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
18 R&D Scale Manufacturing: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
19 Commercial-Scale Manufacturing: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
20 Regional Analysis: Global Cell & Gene Therapy Manufacturing Market, By Region, 2020-2028 (USD Million)
21 North America: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
22 North America: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
23 North America: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
24 North America: Cell & Gene Therapy Manufacturing Market, By Country, 2020-2028 (USD Million)
25 U.S: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
26 U.S: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
27 U.S: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
28 Canada: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
29 Canada: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
30 Canada: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
31 Mexico: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
32 Mexico: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
33 Mexico: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
34 Europe: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
35 Europe: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
36 Europe: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
37 Europe: Cell & Gene Therapy Manufacturing Market, By Country, 2020-2028 (USD Million)
38 Germany: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
39 Germany: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
40 Germany: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
41 UK: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
42 UK: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
43 UK: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
44 France: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
45 France: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
46 France: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
47 Italy: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
48 Italy: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
49 Italy: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
50 Spain: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
51 Spain: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
52 Spain: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
53 Netherlands: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
54 Netherlands: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
55 Netherlands: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
56 Rest Of Europe: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
57 Rest Of Europe: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
58 Rest Of Europe: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
59 Asia Pacific: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
60 Asia Pacific: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
61 Asia Pacific: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
62 Asia Pacific: Cell & Gene Therapy Manufacturing Market, By Country, 2020-2028 (USD Million)
63 China: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
64 China: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
65 China: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
66 India: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
67 India: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
68 India: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
69 Japan: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
70 Japan: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
71 Japan: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
72 South Korea: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
73 South Korea: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
74 South Korea: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
75 Thailand: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
76 Thailand: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
77 Thailand: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
78 Indonesia: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
79 Indonesia: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
80 Indonesia: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
81 Malaysia: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
82 Malaysia: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
83 Malaysia: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
84 Singapore: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
85 Singapore: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
86 Singapore: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
87 Vietnam: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
88 Vietnam: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
89 Vietnam: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
90 Rest of APAC: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
91 Rest of APAC: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
92 Rest of APAC: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
93 Middle East & Africa: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
94 Middle East & Africa: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
95 Middle East & Africa: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
96 Middle East & Africa: Cell & Gene Therapy Manufacturing Market, By Country, 2020-2028 (USD Million)
97 Saudi Arabia: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
98 Saudi Arabia: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
99 Saudi Arabia: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
100 UAE: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
101 UAE: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
102 UAE: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
103 South Africa: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
104 South Africa: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
105 South Africa: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
106 Israel: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
107 Israel: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
108 Israel: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
109 Rest of MEA: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
110 Rest of MEA: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
111 Rest of MEA: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
112 Central & South America: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
113 Central & South America: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
114 Central & South America: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
115 Central & South America: Cell & Gene Therapy Manufacturing Market, By Country, 2020-2028 (USD Million)
116 Brazil: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
117 Brazil: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
118 Brazil: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
119 Argentina: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
120 Argentina: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
121 Argentina: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
122 Chile: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
123 Chile: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
124 Chile: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
125 Rest of CSA: Cell & Gene Therapy Manufacturing Market, By Type Scope, 2020-2028 (USD Million)
126 Rest of CSA: Cell & Gene Therapy Manufacturing Market, By Workflow, 2020-2028 (USD Million)
127 Rest of CSA: Cell & Gene Therapy Manufacturing Market, By Scale, 2020-2028 (USD Million)
128 Thermo Fischer Scientific: Products Offered
129 Lonza: Products Offered
130 Merck KGaA: Products Offered
131 Catalent Inc.: Products Offered
132 Takara: Products Offered
133 Samsung Biologics: Products Offered
134 Charles River: Products Offered
135 Novartis AG: Products Offered
136 Apceth Biopharm: Products Offered
137 Other Companies: Products Offered
List of Figures
1. Global Cell & Gene Therapy Manufacturing Market Segmentation & Research Scope
2. Primary Research Partners and Local Informers
3. Primary Research Process
4. Primary Research Approaches
5. Primary Research Responses
6. Global Cell & Gene Therapy Manufacturing Market: Penetration & Growth Prospect Mapping
7. Global Cell & Gene Therapy Manufacturing Market: Value Chain Analysis
8. Global Cell & Gene Therapy Manufacturing Market Drivers
9. Global Cell & Gene Therapy Manufacturing Market Restraints
10. Global Cell & Gene Therapy Manufacturing Market Opportunities
11. Global Cell & Gene Therapy Manufacturing Market Challenges
12. Key Cell & Gene Therapy Manufacturing Market Manufacturer Analysis
13. Global Cell & Gene Therapy Manufacturing Market: Porter’s Five Forces Analysis
14. PESTLE Analysis & Impact Analysis
15. Thermo Fischer Scientific: Company Snapshot
16. Thermo Fischer Scientific: Swot Analysis
17. Lonza: Company Snapshot
18. Lonza: Swot Analysis
19. Merck KGaA: Company Snapshot
20. Merck KGaA: Swot Analysis
21. Catalent Inc.: Company Snapshot
22. Catalent Inc.: Swot Analysis
23. Takara: Company Snapshot
24. Takara: Swot Analysis
25. Charles River: Company Snapshot
26. Charles River: Swot Analysis
27. Novartis AG: Company Snapshot
28. Novartis AG: Swot Analysis
29. Apceth Biopharm: Company Snapshot
30. Apceth Biopharm: Swot Analysis
31. Samsung Biologics: Company Snapshot
32. Samsung Biologics: Swot Analysis
33. Other Companies: Company Snapshot
34. Other Companies: SWOT Analysis
The Global Cell & Gene Therapy Manufacturing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Cell & Gene Therapy Manufacturing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
